OKYO Pharma Ltd
OKYO
Company Profile
Business description
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Contact
14/15 Conduit Street
Floor 4
LondonW1S 2XJ
GBRT: +44 2074952379
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2025
Employees
3
Stocks News & Analysis
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
Shockwaves from Monday's AI stock panic in the US were largely confined to two ASX industries.
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what this could mean for investors.
stocks
AI stock rout: The US selloff in 4 charts
Worries about Western AI dominance permeated the markets, with Nvidia stock plunging 17% alongside other chipmakers, utilities, and more.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,745.90 | 45.20 | 0.52% |
| CAC 40 | 7,941.64 | 69.16 | 0.88% |
| DAX 40 | 21,727.20 | 89.67 | 0.41% |
| Dow JONES (US) | 44,881.64 | 168.12 | 0.38% |
| FTSE 100 | 8,646.88 | 89.07 | 1.04% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,681.75 | 49.43 | 0.25% |
| Nikkei 225 | 39,513.97 | 99.19 | 0.25% |
| NZX 50 Index | 12,928.38 | 74.66 | -0.57% |
| S&P 500 | 6,071.18 | 31.87 | 0.53% |
| S&P/ASX 200 | 8,493.70 | 46.70 | 0.55% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |